Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 1.2. It has been cited 44 times, with 38 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.571
From this paper's citation signal
Citation Network Contribution
0.632
From 22 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 38 citers.
National Institutes of Health
Grant: R01DK057846,R21 AI166387,R01DK129523,P30DK045735,P30S10OD030363. U01 DK061010,U01 DK061034,U01 DK061042,U01 DK061058,U01 DK085453,U01 DK085461,U01 DK085465,U01 DK085466,U01 DK085476,U01 DK085499,U01 DK085504,U01 DK085509,U01 DK103180,U01 DK103153,U01 DK10
Juvenile Diabetes Research Foundation International
Grant: 2-SRA-2019-833-S-B
NIDDK NIH HHS
Grant: U01 DK085466
NIDDK NIH HHS
Grant: U01 DK061010
NIDDK NIH HHS
Grant: U01 DK103180
NCATS NIH HHS
Grant: UL1 TR001863
NIDDK NIH HHS
Grant: U01 DK061034
NIDDK NIH HHS
Grant: U01 DK061058
NIDDK NIH HHS
Grant: U01 DK085476
NIDDK NIH HHS
Grant: U01 DK085504
NIDDK NIH HHS
Grant: U01 DK085509
NIDDK NIH HHS
Grant: R01 DK057846
NIDDK NIH HHS
Grant: U01 DK061042
NIDDK NIH HHS
Grant: U01 DK085453
NIDDK NIH HHS
Grant: R01 DK129523
NIAID NIH HHS
Grant: R21 AI166387
NIDDK NIH HHS
Grant: U01 DK085499
NIDDK NIH HHS
Grant: U01 DK103153
NIDDK NIH HHS
Grant: P30 DK045735
NIDDK NIH HHS
Grant: U01 DK085461
NIDDK NIH HHS
Grant: U01 DK106993
NIH HHS
Grant: S10 OD030363
NIDDK NIH HHS
Grant: U01 DK085465
National Institutes of Health
Grant: 5U01DK103153-03
Chicagoland Diabetes TrialNet Clinical Center
National Institutes of Health
Grant: 1U01DK085509-01
Trainet: Diabetes Type 1 Prevention
National Institutes of Health
Grant: 5U01DK061058-15
Prediction and Prevention of Type 1 Diabetes (TrialNet)
National Institutes of Health
Grant: 5U01DK085465-03
Vanderbilt University: Clinical Center Application, Type 1 Diabetes TrialNet
National Institutes of Health
Grant: 2U01DK106993-07
Data Coordinating Center for Type 1 Diabetes TrialNet
National Institutes of Health
Grant: 5U01DK061034-07
Northwest Clinical Center for Type 1 Diabetes - TrialNet
National Institutes of Health
Grant: 1U01DK061010-01
UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)
National Institutes of Health
Grant: 5U01DK085504-05
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University
National Institutes of Health
Grant: 3R01DK057846-10S1
Phase II Trial of HOKT3gamma 1 (ALA-ALA) in Type 1 Diabetes
National Institutes of Health
Grant: 5U01DK085466-02
Type 1 Diabetes TrialNet: Clinical Center at Yale University (U01)
National Institutes of Health
Grant: 5U01DK085476-03
Type 1 Diabetes-A Proposal for Prevention & Intervention
National Institutes of Health
Grant: 1U01DK085453-01
Type 1 Diabetes TrialNet: Clinical Centers (U01)
National Institutes of Health
Grant: 5P30DK045735-28
Yale Diabetes Research Center
National Institutes of Health
Grant: 5U01DK061042-16
TrialNet at Stanford University
National Institutes of Health
Grant: 5U01DK085461-10
TrialNet: University of Florida Clinical Center and Network
National Institutes of Health
Grant: 5U01DK085499-03
Type 1 Diabetes TrialNet Clinical Center: Effects of Alefacept in New Onset T1D
National Institutes of Health
Grant: 1R01DK129523-01
Adaptive epigenetic mechanisms of beta and immune cells in autoimmune diabetes
National Institutes of Health
Grant: 5U01DK103180-03
Texas Children's Hospital and Baylor College of Medicine TrialNet Clinical Center
National Institutes of Health
Grant: 1R21AI166387-01
Effects of EBV on autoimmunity and responses to immune therapy
FWCI
17.71
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords